author-photo

Pauline Veyrard

17

Papers

50

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug Levels.

2021 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter Study.

2020 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (8)
Mo1161 THE SIMPLIFIED MARIA SCORE IS STRONGLY CORRELATED WITH THE MARIA AND CLERMONT SCORES TO ANALYSE THE LUMINAL ACTIVITY OF CROHN'S DISEASE IN MAGNETIC RESONANCE AND IS EASIER TO CALCULATE

2020 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification

2020 Digestive Diseases and Sciences
Show All
- Source
- Cite
- Save
Citations (1)
Infliximab therapy intensification upon loss of response: Is there an optimal trough level?

2019 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (3)
OP24 Effectiveness and safety of ustekinumab 90 mg every 4 weeks in Crohn’s disease

2019 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (4)
P565 Infliximab therapy intensification upon loss of response: what should be the cut-off for trough levels?

2019 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial

2019 Clinical Gastroenterology and Hepatology
Show All
- Source
- Cite
- Save
Citations (15)
Les limites de l’optimisation des anti-TNF

2019
Show All
- Source
- Cite
- Save
Citations (0)
Cicatrisation histologique au cours des MICI : jusqu’où optimiser ?

2019
Show All
- Source
- Cite
- Save
Citations (0)